Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5972595 | 0.83 | KMT2A (0.56) | KMT2AMEN1CYP3A4ALDH1A1MAPK1 | |
| SCHEMBL11133357 | 0.80 | KMT2A (0.54) | KMT2AMEN1CYP3A4ALDH1A1MAPK1 | |
| SCHEMBL29816603 | 0.80 | CYP3A4 (0.54) | KMT2AMEN1CYP3A4ALDH1A1HSD17B10 | |
| SCHEMBL9271743 | 0.79 | ALDH1A1 (0.67) | KMT2AMEN1CYP3A4ALDH1A1MAPK1 | |
| SCHEMBL1188292 | 0.79 | ALDH1A1 (0.62) | KMT2AMEN1ALDH1A1MAPK1HSD17B10 | |
| SCHEMBL11852070 | 0.78 | NLRP3 (0.60) | KMT2AMEN1CYP3A4ALDH1A1KDM4E | |
| SCHEMBL160077 | 0.77 | NPC1 (0.54) | KMT2AMEN1CYP3A4MAPK1HSD17B10 | |
| SCHEMBL9493549 | 0.77 | ALDH1A1 (0.54) | KMT2AMEN1CYP3A4ALDH1A1MAPK1 | |
| SCHEMBL11552687 | 0.77 | L3MBTL1 (0.54) | KMT2AMEN1CYP3A4ALDH1A1MAPK1 | |
| SCHEMBL16589882 | 0.77 | KMT2A (0.50) | KMT2AMEN1CYP3A4ALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | BCAT1, BCAT2, PELP1 | KMT2A 3415/4885MEN1 4354/4885CYP3A4 3633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.